$44.24
Above FV▼ -17.4% against the close used
Model range $3.62 – $65.27
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear$3.62Fair value$44.24Bull$65.27
FairClose
52-week traded range
52W low $40.1852W high $57.72
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
American Healthcare REIT closed at $53.58, 21.1% above the consensus fair value of $44.24 drawn from 9 valuation models.
Financial DNA score 33/100 — Weak. P/E of 127.6x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
$8.34
-84.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
$13.45
-74.9%
√(22.5 × EPS × BVPS)
EPS=0.42, BVPS=19.14 · outside Graham range (P/E 127.6, P/B 2.8) — asset-light, treat as a rough floor
P/E Fair Value
$8.40
-84.3%
EPS × 20x (sector P/E)
EPS=0.42, Sector P/E=20x
Peter Lynch (PEG)
$12.60
-76.5%
EPS × Growth% (PEG = 1 is fair)
EPS=0.42, g=30%
EV/EBITDA
$65.27
+21.8%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=602.72M
Dividend Discount (DDM)
$54.11
+1.0%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=1, r=10%, g=8%
Book Value (P/B)
$3.62
-93.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=19.14, ROE=1.9%, g=6%, r=10%
Reverse DCF
$53.58
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 32.6% | Historical: 40%
Margin of Safety
$7.55
-85.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=10.06, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.